New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice

L. Bolondi, J. M. Correas, Riccardo Lencioni, H. P. Weskott, F. Piscaglia

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

The introduction of second-generation microbubble ultrasound contrast agents and the development of contrast specific ultrasound techniques have improved the ability of contrast enhanced ultrasound in detecting and characterising liver lesions, offering new perspectives for its exploitation in clinical hepatology. Indeed, several studies have demonstrated a high diagnostic accuracy in focal lesion characterisation (85-96%) in patients either with or without underlying chronic liver disease. This review article describes the basic principles of contrast enhanced ultrasound, defines the different vascular features of benign and malignant liver lesions, and assesses its clinical impact in different clinical scenarios, according to the guidelines of the European Federation of Societies for Ultrasound in Medicine and Biology, contrast enhanced ultrasound enables the characterisation of focal liver lesions, regardless of the presence or absence of underlying chronic liver disease. Contrast enhanced ultrasound is also useful in staging and follow-up of cancer patients and in monitoring local ablative treatment. Contrast enhanced ultrasound is expected to be considerably increased and replace many computed tomography and magnetic resonance imaging examinations in near future, according to the European Federation of Societies for Ultrasound in Medicine and Biology guidelines. Therefore, it is necessary to take measures in order to meet the demand for an increasing number of these procedures.

Original languageEnglish (US)
Pages (from-to)187-195
Number of pages9
JournalDigestive and Liver Disease
Volume39
Issue number2
DOIs
StatePublished - Feb 2007
Externally publishedYes

Fingerprint

Liver Diseases
Liver
Chronic Disease
Guidelines
Microbubbles
Physiologic Monitoring
Gastroenterology
Contrast Media
Blood Vessels
Tomography
Magnetic Resonance Imaging
Neoplasms
Therapeutics

Keywords

  • CEUS
  • Diagnosis
  • Hepatocellular carcinoma
  • Liver metastases
  • Ultrasound contrast agents

ASJC Scopus subject areas

  • Gastroenterology

Cite this

New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. / Bolondi, L.; Correas, J. M.; Lencioni, Riccardo; Weskott, H. P.; Piscaglia, F.

In: Digestive and Liver Disease, Vol. 39, No. 2, 02.2007, p. 187-195.

Research output: Contribution to journalArticle

Bolondi, L, Correas, JM, Lencioni, R, Weskott, HP & Piscaglia, F 2007, 'New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice', Digestive and Liver Disease, vol. 39, no. 2, pp. 187-195. https://doi.org/10.1016/j.dld.2006.08.008
Bolondi, L. ; Correas, J. M. ; Lencioni, Riccardo ; Weskott, H. P. ; Piscaglia, F. / New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. In: Digestive and Liver Disease. 2007 ; Vol. 39, No. 2. pp. 187-195.
@article{1afc8f6ed9f14ed68b13d6f93a6037f2,
title = "New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice",
abstract = "The introduction of second-generation microbubble ultrasound contrast agents and the development of contrast specific ultrasound techniques have improved the ability of contrast enhanced ultrasound in detecting and characterising liver lesions, offering new perspectives for its exploitation in clinical hepatology. Indeed, several studies have demonstrated a high diagnostic accuracy in focal lesion characterisation (85-96{\%}) in patients either with or without underlying chronic liver disease. This review article describes the basic principles of contrast enhanced ultrasound, defines the different vascular features of benign and malignant liver lesions, and assesses its clinical impact in different clinical scenarios, according to the guidelines of the European Federation of Societies for Ultrasound in Medicine and Biology, contrast enhanced ultrasound enables the characterisation of focal liver lesions, regardless of the presence or absence of underlying chronic liver disease. Contrast enhanced ultrasound is also useful in staging and follow-up of cancer patients and in monitoring local ablative treatment. Contrast enhanced ultrasound is expected to be considerably increased and replace many computed tomography and magnetic resonance imaging examinations in near future, according to the European Federation of Societies for Ultrasound in Medicine and Biology guidelines. Therefore, it is necessary to take measures in order to meet the demand for an increasing number of these procedures.",
keywords = "CEUS, Diagnosis, Hepatocellular carcinoma, Liver metastases, Ultrasound contrast agents",
author = "L. Bolondi and Correas, {J. M.} and Riccardo Lencioni and Weskott, {H. P.} and F. Piscaglia",
year = "2007",
month = "2",
doi = "10.1016/j.dld.2006.08.008",
language = "English (US)",
volume = "39",
pages = "187--195",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice

AU - Bolondi, L.

AU - Correas, J. M.

AU - Lencioni, Riccardo

AU - Weskott, H. P.

AU - Piscaglia, F.

PY - 2007/2

Y1 - 2007/2

N2 - The introduction of second-generation microbubble ultrasound contrast agents and the development of contrast specific ultrasound techniques have improved the ability of contrast enhanced ultrasound in detecting and characterising liver lesions, offering new perspectives for its exploitation in clinical hepatology. Indeed, several studies have demonstrated a high diagnostic accuracy in focal lesion characterisation (85-96%) in patients either with or without underlying chronic liver disease. This review article describes the basic principles of contrast enhanced ultrasound, defines the different vascular features of benign and malignant liver lesions, and assesses its clinical impact in different clinical scenarios, according to the guidelines of the European Federation of Societies for Ultrasound in Medicine and Biology, contrast enhanced ultrasound enables the characterisation of focal liver lesions, regardless of the presence or absence of underlying chronic liver disease. Contrast enhanced ultrasound is also useful in staging and follow-up of cancer patients and in monitoring local ablative treatment. Contrast enhanced ultrasound is expected to be considerably increased and replace many computed tomography and magnetic resonance imaging examinations in near future, according to the European Federation of Societies for Ultrasound in Medicine and Biology guidelines. Therefore, it is necessary to take measures in order to meet the demand for an increasing number of these procedures.

AB - The introduction of second-generation microbubble ultrasound contrast agents and the development of contrast specific ultrasound techniques have improved the ability of contrast enhanced ultrasound in detecting and characterising liver lesions, offering new perspectives for its exploitation in clinical hepatology. Indeed, several studies have demonstrated a high diagnostic accuracy in focal lesion characterisation (85-96%) in patients either with or without underlying chronic liver disease. This review article describes the basic principles of contrast enhanced ultrasound, defines the different vascular features of benign and malignant liver lesions, and assesses its clinical impact in different clinical scenarios, according to the guidelines of the European Federation of Societies for Ultrasound in Medicine and Biology, contrast enhanced ultrasound enables the characterisation of focal liver lesions, regardless of the presence or absence of underlying chronic liver disease. Contrast enhanced ultrasound is also useful in staging and follow-up of cancer patients and in monitoring local ablative treatment. Contrast enhanced ultrasound is expected to be considerably increased and replace many computed tomography and magnetic resonance imaging examinations in near future, according to the European Federation of Societies for Ultrasound in Medicine and Biology guidelines. Therefore, it is necessary to take measures in order to meet the demand for an increasing number of these procedures.

KW - CEUS

KW - Diagnosis

KW - Hepatocellular carcinoma

KW - Liver metastases

KW - Ultrasound contrast agents

UR - http://www.scopus.com/inward/record.url?scp=33846285727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846285727&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2006.08.008

DO - 10.1016/j.dld.2006.08.008

M3 - Article

C2 - 17208526

AN - SCOPUS:33846285727

VL - 39

SP - 187

EP - 195

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 2

ER -